RIZA MALANA: Open Payments
NPI 1477141711 · CAMARILLO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 29 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $595 · 2025 $1,311
Food & beverage: $1,304Education: $7
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $363 |
| AKEBIA THERAPEUTICS INC | 3 | $260 |
| Amgen Inc. | 6 | $189 |
| Otsuka America Pharmaceutical, Inc. | 6 | $147 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Ardelyx, Inc. | 1 | $114 |
| Lilly USA, LLC | 2 | $57 |
| Alexion Pharmaceuticals, Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Calliditas Therapeutics US Inc. | 1 | $14 |
Products named: Vafseo, LOKELMA, KRYSTEXXA, JYNARQUE, BENLYSTA, XPHOZAH 30 MG, FARXIGA, JARDIANCE.
Industry payments across CA — which companies pay providers there.
